386 related articles for article (PubMed ID: 32821131)
1. Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant
Li D; Liao W; Huang HH; Du FL; Wei DD; Mei YF; Long D; Wan LG; Liu Y; Zhang W
Infect Drug Resist; 2020; 13():2673-2680. PubMed ID: 32821131
[TBL] [Abstract][Full Text] [Related]
2. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
3. Isolation of Hv-CRKP with co-production of three carbapenemases (
Li P; Luo WY; Xiang TX; Peng TX; Luo S; He ZY; Liao W; Wei DD; Liu P; Wan LG; Zhang W; Liu Y
Front Microbiol; 2023; 14():1182870. PubMed ID: 37293218
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of a Stable and Transferable
Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B
Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression and Amplification of
Li X; Zhang J; Yang C; Li J; Wang J; Huang W; Zeng L; Liang X; Long W; Zhang X
Microbiol Spectr; 2022 Aug; 10(4):e0095522. PubMed ID: 35900090
[TBL] [Abstract][Full Text] [Related]
6. Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing
Errico G; Del Grosso M; Pagnotta M; Marra M; Carollo M; Cerquetti M; Fogato E; Cesana E; Gentiloni Silverj F; Zabzuni D; Rossini A; Pantosti A; Tinelli M; Monaco M; Giufrè M
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627702
[TBL] [Abstract][Full Text] [Related]
7. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
[TBL] [Abstract][Full Text] [Related]
8. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in
Giddins MJ; Macesic N; Annavajhala MK; Stump S; Khan S; McConville TH; Mehta M; Gomez-Simmonds A; Uhlemann AC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263067
[TBL] [Abstract][Full Text] [Related]
9. Role of the ISKpn element in mediating mgrB gene mutations in ST11 hypervirulent colistin-resistant
Zhu L; Li P; Zhang G; He Z; Tao X; Ji Y; Yang W; Zhu X; Luo W; Liao W; Chen C; Liu Y; Zhang W
Front Microbiol; 2023; 14():1277320. PubMed ID: 37840706
[TBL] [Abstract][Full Text] [Related]
10. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant
Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F
mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656
[TBL] [Abstract][Full Text] [Related]
11. An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital.
Zhu J; Jiang X; Zhao L; Li M
mSystems; 2022 Jun; 7(3):e0129721. PubMed ID: 35574716
[TBL] [Abstract][Full Text] [Related]
12. Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella
Guo Y; Liu N; Lin Z; Ba X; Zhuo C; Li F; Wang J; Li Y; Yao L; Liu B; Xiao S; Jiang Y; Zhuo C
Emerg Microbes Infect; 2021 Dec; 10(1):2042-2051. PubMed ID: 34551677
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Hypervirulent ST11-K64
Wei T; Zou C; Qin J; Tao J; Yan L; Wang J; Du H; Shen F; Zhao Y; Wang H
Front Public Health; 2022; 10():765624. PubMed ID: 35309213
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftazidime/avibactam against carbapenem-nonsusceptible Klebsiella penumoniae isolates collected during the first wave of the SARS-CoV-2 pandemic: a Southern Italy, multicenter, surveillance study.
La Bella G; Lopizzo T; Lupo L; Angarano R; Curci A; Manti B; La Salandra G; Mosca A; De Nittis R; Arena F
J Glob Antimicrob Resist; 2022 Dec; 31():236-238. PubMed ID: 36208851
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study.
Wei J; Zou C; Wang D; Huang A; Niu S
J Glob Antimicrob Resist; 2020 Sep; 22():448-451. PubMed ID: 32387260
[TBL] [Abstract][Full Text] [Related]
16. Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing
Cui X; Shan B; Zhang X; Qu F; Jia W; Huang B; Yu H; Tang YW; Chen L; Du H
Front Microbiol; 2020; 11():1365. PubMed ID: 32655534
[No Abstract] [Full Text] [Related]
17. Retrospective Tertiary Care-Based Cohort Study on Clinical Characteristics and Outcomes of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant
Ahmed F; Abraham B; Kamal Saeed N; Mohamed Naser H; Sridharan K
Crit Care Res Pract; 2024; 2024():3427972. PubMed ID: 38868174
[TBL] [Abstract][Full Text] [Related]
18. Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Pu D; Zhao J; Lu B; Zhang Y; Wu Y; Li Z; Zhuo X; Cao B
Int J Antimicrob Agents; 2023 Apr; 61(4):106747. PubMed ID: 36758779
[TBL] [Abstract][Full Text] [Related]
19. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Gaibani P; Lewis RE; Volpe SL; Giannella M; Campoli C; Landini MP; Viale P; Re MC; Ambretti S
Int J Infect Dis; 2017 Dec; 65():1-3. PubMed ID: 28951106
[TBL] [Abstract][Full Text] [Related]
20. Emergence of transferable ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae due to a novel CMY AmpC β-lactamase in China.
Xu M; Zhao J; Xu L; Yang Q; Xu H; Kong H; Zhou J; Fu Y
Clin Microbiol Infect; 2022 Jan; 28(1):136.e1-136.e6. PubMed ID: 34044150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
